Minerva Neurosciences, Inc.
NERV · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $11,899 | $12,705 | $14,649 | $32,039 |
| G&A Expenses | $9,950 | $10,414 | $10,582 | $13,327 |
| SG&A Expenses | $9,950 | $10,414 | $10,582 | $13,327 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $21,848 | $23,120 | $25,231 | $45,366 |
| Operating Income | -$21,848 | -$23,120 | -$25,231 | -$45,366 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $23,287 | -$6,886 | -$6,877 | -$6,344 |
| Pre-Tax Income | $1,439 | -$30,005 | -$32,109 | -$51,709 |
| Tax Expense | $0 | $0 | $0 | -$1,803 |
| Net Income | $1,439 | -$30,005 | -$32,109 | -$49,906 |
| % Margin | – | – | – | – |
| EPS | 0.19 | -4.61 | -6.01 | -9.35 |
| % Growth | 104.1% | 23.3% | 35.7% | – |
| EPS Diluted | 0.19 | -4.61 | -6.01 | -9.35 |
| Weighted Avg Shares Out | 7,569 | 6,506 | 5,340 | 5,340 |
| Weighted Avg Shares Out Dil | 7,574 | 6,506 | 5,340 | 5,340 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,272 | $1,437 | $557 | $17 |
| Interest Expense | $4,562 | $8,283 | $7,407 | $6,327 |
| Depreciation & Amortization | $22 | $31 | $9 | $102 |
| EBITDA | $6,024 | -$21,691 | -$24,694 | -$45,280 |
| % Margin | – | – | – | – |